PD-L2 protein expression in human tumors was associated with clinical response to pembrolizumab (Keytruda), an anti-PD-1 immunotherapy, independent of PD-L1 expression, in patients with head and neck squamous cell carcinoma (HNSCC).
This post comes from the RSS feed of EurekaAlert, you can find more here!
Welcome to The Ether Gauge Theory!
Here, we love science and love talking about theories!
You will find the most interesting stuff here, what you have never heard before!
If you love science, stay tuned!